They are suitable for a wide variety of markets and applications, including: • Lawn and garden equipment • Tools and hardware • Consumer disposables • Sports/shooting sports Omnicolor is not suitable for FDA primary pharmaceutical packaging, cosmetic or medical applications, and may have limited food contact compliance.

Applications include: • Automotive pillars, headliners, and other visible interior trim parts • Home appliances • Consumer products • Personal electronics devices • Medical devices • Sporting goods & toys • Outdoor furniture www.avient.com Copyright © 2020, Avient Corporation.

CHEMICAL RESISTANT TPEs ADD FUNCTIONALITY THAT BRINGS VALUE TO CONSUMERS • Chemical Resistance – Resists aggressive soaps, detergents, lotions, oils and solvents found in cosmetic, personal care and household products • Regulatory* – Compositionally compliant with certain FDA and REACH regulations • Value – Economical alternative to silicone and over-engineered medical grade TPEs • Easy to Process – Can be injection molded and overmolded right onto the substrate including PP, ABS, etc

Avient Colorants Sweden AB in Malmoe and Avient Colorants USA LLC in Lewiston, Maine are Medical Centers of Competence with an external ISO 13485 certification. Core processes that may be additional at the ISO 13485 sites include the following as they relate to the Mevopur medical line of products: Change control All changes concerning any Mevopur products are evaluated to determine whether there will be any impact on the product specification or the quality of the product. Records are established and maintained for each batch of medical products that provides traceability and identifies the amount manufactured and amount approved for distribution.

FOUR MAIN PLASTIC VARIABLES Flow Rate Plastics are a non-Newtonian fluid, therefore, with a higher shear rate, the viscosity of the material is reduced. This will result in stronger parts due to the locked in FIGURE 43 - Non-Newtonian Fluid Flow Low Level of Orientation Frozen Layer Highly Oriented Laminates Gate Transducer A Transducer B Hydraulic x 10 Filling Hold Start of mold shrinkage Time Pack P ss A B FIGURE 45 - Non-Newtonian fluid flow Relative Viscosity = Transfer Position * Fill Time Shear Rate = 1 Fill time FIGURE 46 - Pressure vs. Reduce the clamp tonnage until flash is seen around the parting line, then increase the clamp tonnage by 5-10% Minimize Cycle Time • Mold Open/Close – Should be as fast as possible, without slamming, and still produce a nice fluid motion • Ejector Speed – As fast as possible, without influencing part quality • Ejector Stroke – Only stroke the ejectors as many times as needed to separate the part from the core - i.e.

Nikrant Page 67 United States 36% Europe 36% Canada 2% Asia 20% Latin America 2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions At a Glance Appliance 6% Building & Construction 3% Wire & Cable 14% Electrical & Electronics 14%Consumer 21% Packaging 5% Industrial 8% Misc. 3% HealthCare 5% Transportation 21% America 6% 2011 Revenue by Industry Segment2011 Revenue by Industry Segment 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 12-16% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales Target Expanding ProfitsExpanding Profits Page 68 Value Proposition • GSEM is a global leader providing complete specialty solutions encompassing innovative technologies and services to enable customer success Transformation Highlights • Dramatic turnaround of the Engineered Materials business through mix improvement and specialty focus Value Proposition and Transformation Highlights improvement and specialty focus • GLS acquisition successfully integrated, having more than doubled earnings in 3 years • PolyOne culture and strategy now engrained worldwide • Expansion into healthcare with dedicated resources > $15B Addressable Market Page 69 • Polymer design, formulation and service expertise • Broad, global technology base and regional centers of excellence • Ten innovation centers around the world Key Differentiators • Ten innovation centers around the world • Specialty brand leadership with PolyOne, GLS, NEU and ECCOH • Ability to leverage global key account team Page 70 From Volume Commodity-driven product portfolio To Value Specialty technology and solutions EM North America Transformation Volume Sales Gross Margin $ Mix Transformation – Executing the Strategy 2006 2011 2006 2011 2006 2011 Page 71 $12 $29 Operating Income ($ in millions) • Provided access to new customers in specialized, high-growth markets such as healthcare and consumer • Strategic partner to many of the world’s best-known companies GLS Integration Success 16.9% 8.2% 2007 2011 2007 2011 Working Capital % of Sales • Complementary global footprint provided additional cross-selling opportunities • Opportunity to expand margins and drive working capital improvement while remaining customer-focused Page 72 $1.3 $27.6 2006 2011 Healthcare Revenue • Investment in dedicated healthcare team to drive penetration and growth • Leverage product portfolio globally & win specialty business Areas of Focus $10.5 $117.9 2006 2011 Consumer Revenue 2006 2011globally & win specialty business in targeted markets • Aggressively commercialize specialty innovation platforms • Utilize our innovation centers to influence OEM design (Revenue in $ millions) Page 73 • Carbon Nanotube Formulations � Applications: Semiconductor equipment, hard drives � Customer benefits: Scrap cost reduction and clean conductivity • Thermally Conductive Solutions Applications: Sockets and bulb holders for LED lighting Key Innovations � Applications: Sockets and bulb holders for LED lighting � Customer benefits: Cost reduction, energy saving, and design flexibility • FDA-Regulated TPEs � Applications: Food packaging seals, intravenous delivery systems, medical stoppers, prefilled syringes � Customer benefits: Clean and safe elastomers for highly regulated applications Page 74 Critical Imperatives and 2015 Goal Critical Imperatives • Commercialize critical new technology platforms • Manage the mix as we continue to drive the transformation • Global translation of commercial successes 2015 Goal • 12 - 16% return on sales Page 75 Page 76

HealthCare Transportation 8% Textiles Target Page 85 • Trend toward more affordable housing favors our product 1.5 2.0 2.5 Housing Starts (in million units) 50 year average Market Dynamics • Ultimate housing recovery presents substantial upside to already record- setting results Source: Historical Data from the US Census Bureau, 2012 estimate is a PolyOne projection. 0.0 0.5 1.0 '87 '89 '91 '94 '96 '98 '00 '02 '04 '06 '08 '10 '12 Page 86 Value Proposition • Premier provider of specialized vinyl and supply chain solutions, leading the industry in innovation and service Transformation Highlights • Management upgrades ensure that each PP&S business Value Proposition and Transformation Highlights • Management upgrades ensure that each PP&S business maximizes performance • Asset realignment and Lean Six Sigma reduce costs • Strengthened relationship with winning customers • Increased differentiation in all business units > $12B Addressable Market Page 87 Key Differentiators • Providing application design, material design and / or process design assistance not available from competitors • Capability to improve joint value streams • We are the best innovator in our space • We are the best innovator in our space • Expanding customers’ opportunities by providing innovative materials and marketing ideas • We provide world-class customer service and delivery performance Page 88 13.7% 14.3% 15.5% 9.9% 6.2% 5.4% WC % of Sales • Best-in-class working capital management and delivery performance • Improved raw material Areas of Focus – Operational Excellence 89.1% 92.0% 94.2% 93.4% 93.4% 94.0% On-Time Delivery • Improved raw material positions, sourcing savings • PolyOne pilot site for many LSS and manufacturing excellence programs *As measured to customer request date * Page 89 • reFlexTM Bioplasticizers Applications: Wide variety of flexible vinyl-based products • GeonTM HC for Healthcare � Applications: Medical device housings, specialty tubing � Customer benefits: Withstand aggressive antiseptics Key Innovations � Applications: Wide variety of flexible vinyl-based products � Customer benefits: Lower carbon footprint, improved productivity • GeonTM SF Super Flow � Applications: Large appliance parts, molded siding panels � Customer benefits: Flame retardancy, detergent resistance Page 90 Critical Imperatives and 2015 Goal Critical Imperatives • Accelerate innovation - grow in new applications not historically served with vinyl • Drive continuous improvement in manufacturing and working capital efficienciesworking capital efficiencies • Selectively leverage construction recovery 2015 Goal • 9 - 12% return on sales Page 91 Page 92

KEY FEATURES • High temperature resistance • Biocompatible • Brilliant colors • Multi sterilizable • Hydrolytic stability • Chemical resistance • Flame resistance • High mechanical performance • Food contact compliant APPLICATIONS • FDA medical & dental devices • Sterilization trays • Aircraft interiors • Automotive lighting • Chemical handling • Sensors and pumps • Plumbing fittings & manifolds • Food service trays • Gears & bushings • Membranes • Connectors For more information, email info.colorant.chromatics@avient.com or call +1.860.626.3029 1.844.4AVIENT www.avient.com Copyright © 2021, Avient Corporation.

16 2021 O U TLO O K Synergies ($ millions) Initial Three-Year Estimate Revised Three-Year Estimate 2021 Expected Realization Administrative $ 18 $ 20 $ 15 Sourcing 24 30 15 Operational 18 25 5 Total Synergies $ 60 $ 75 $ 35 CLARIANT INTEGRATION & COST SYNERGIES UPDATE 18 • Integration going extremely well: synergy target increased from $60 million to $75 million • $5 million of synergies in 2020 and expect to realize $35 million in 2021 • Relentless focus on guiding principles of safety first, employee collaboration and exceeding customer expectations • Future revenue synergies are not part of these estimates and represent additional growth over the long term $86 $103 $0.53 $0.70 ORGANIC GROWTH PROJECTIONS – Q1 19 Sales Adjusted Operating Income $991 $1,090 + 10% Adjusted EPS + 20% + 32% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition $308 $360 $1.93 $2.40 ORGANIC GROWTH PROJECTIONS – FULL YEAR 20 Sales Adjusted Operating Income $3,783 $4,100 + 8% Adjusted EPS + 17% + 24% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (in millions) (in millions) 2020 Pro forma $3,783 $308 Sustainable Solutions 60 11% 24 Healthcare 60 11% 18 Composites 20 10% 10 Growth in Emerging Regions 50 7% 11 Other (GDP growth) 82 5% 11 Sub-total $4,055 7% $382 COVID Response Applications (25) - (11) Outdoor High Performance Applications (15) - (7) Asia Payroll Tax Subsidy (COVID) - - (4) FX Impact 85 - 7 Synergies - - 30 Incentives, Travel, Other Employee Costs - - (37) 2021 Estimated $4,100 8% $360 2021 ORGANIC SALES AND OPERATING INCOME 21 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) COVID Response Applications: facemasks, personal protective equipment Sales Growth Rate Operating Income$ millions (2) CASH FLOW AND LEVERAGE 22 • Asset light business generates significant free cash flow • Cash generation in 2021 partially offset by restructuring activities to capture synergies associated with the Clariant Masterbatch acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition ($ millions) 2020 2021E Adjusted EBITDA 382 510 Working Capital: Source / (Use) 116 (30) Cash Taxes (40) (53) Interest Paid (67) (76) CapEx (62) (75) CapEx for Synergy Capture (2) (20) Restructuring for Synergy Capture (11) (25) Other 22 19 Free Cash Flow 338 250 23 • 8% increase in sales drives 24% increase in adjusted EPS to $2.40 ($2.70 excluding step-up depreciation and amortization) as a result of continued growth in sustainable solutions and synergy capture • Clariant synergy capture ahead of schedule: $35M of savings planned from Clariant Masterbatch acquisition • Adjusted EBITDA of $510M – highest level in company history • Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the end of 2021 2021 PROJECTIONS PEER COMPARISONS 24 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.

FX -11% FX -3% Total Avient -14% YoY Comparison against 2022 pro forma results • Aging infrastructure driving need for greater technological advancements and upgrades • Increased focus on strength and capacity of electrical grid plays into further adoption of composites into the market  UV, weather-resistance, customized capabilities  Best-in-class customer responsiveness  Local high-quality manufacturing, unparalleled breadth of portfolio  Expanding position in insulators, utility poles, crossarms, and wind energy Avient Confidential 15 ENERGY 15 • Fiber-optic investments from AT&T, Corning, Commscope continue to drive industry toward innovation • $42B BEAD program in Infrastructure Bill to increase cable deployments; well-positioned to capitalize on “Made in America” requirement and “last mile” buildout  Flame retardance, weather-resistance enables faster, safer, more reliable connections  Local manufacturing, unparalleled breadth of portfolio  Expanding position in insulation for wire jacketing, 5G buildout TELECOMMUNICATIONS Source: U.S.